139 related articles for article (PubMed ID: 7627628)
1. Lack of specificity of HTLV antibody enzyme immunoassays.
Jang D; Mahony JB; Sellors JW; Galli R; Gregory B; Chernesky MA
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(5):523-4. PubMed ID: 7627628
[No Abstract] [Full Text] [Related]
2. Evaluation of a p21e-spiked western blot (immunoblot) in confirming human T-cell lymphotropic virus type I or II infection in volunteer blood donors. The Retrovirus Epidemiology Donor Study Group.
Kleinman SH; Kaplan JE; Khabbaz RF; Calabro MA; Thomson R; Busch M
J Clin Microbiol; 1994 Mar; 32(3):603-7. PubMed ID: 8195365
[TBL] [Abstract][Full Text] [Related]
3. Chimeric synthetic peptides from the envelope (gp46) and the transmembrane (gp21) glycoproteins for the detection of antibodies to human T-cell leukemia virus type II.
Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
Biochem Biophys Res Commun; 2001 Nov; 289(1):7-12. PubMed ID: 11708768
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity and specificity of a recombinant transmembrane glycoprotein (rgp21)-spiked western immunoblot for serological confirmation of human T-cell lymphotropic virus type I and type II infections.
Lal RB; Brodine S; Kazura J; Mbidde-Katonga E; Yanagihara R; Roberts C
J Clin Microbiol; 1992 Feb; 30(2):296-9. PubMed ID: 1347047
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides.
Viscidi RP; Hill PM; Li SJ; Cerny EH; Vlahov D; Farzadegan H; Halsey N; Kelen GD; Quinn TC
J Acquir Immune Defic Syndr (1988); 1991; 4(12):1190-8. PubMed ID: 1941526
[TBL] [Abstract][Full Text] [Related]
6. [Retrovirus: diagnostic tests and their interpretation (II). HIV-2, HTLV-I, and HTLV-II infection].
Soriano V; Gutiérrez M; González-Lahoz J
Med Clin (Barc); 1993 Sep; 101(7):264-8. PubMed ID: 7746003
[No Abstract] [Full Text] [Related]
7. Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.
Bonis J; Baillou A; Barin F; Verdier M; Janvier B; Denis F
J Clin Microbiol; 1993 Jun; 31(6):1481-5. PubMed ID: 8314990
[TBL] [Abstract][Full Text] [Related]
8. Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus.
Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
Biochem Biophys Res Commun; 2001 Nov; 289(1):1-6. PubMed ID: 11708767
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a new, fully automated immunoassay for detection of HTLV-I and HTLV-II antibodies.
Qiu X; Hodges S; Lukaszewska T; Hino S; Arai H; Yamaguchi J; Swanson P; Schochetman G; Devare SG
J Med Virol; 2008 Mar; 80(3):484-93. PubMed ID: 18205214
[TBL] [Abstract][Full Text] [Related]
10. Serological patterns and temporal trends of HTLV-1/2 infection in high-risk populations attending Public Health Units in São Paulo, Brazil.
Jacob F; Santos-Fortuna E; Azevedo RS; Caterino-de-Araujo A
J Clin Virol; 2008 Jun; 42(2):149-55. PubMed ID: 18346935
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a recombinant human T-cell lymphotropic virus type I (HTLV-I) p21E antibody detection enzyme immunoassay as a supplementary test in HTLV-I/II antibody testing algorithms.
Hartley TM; Malone GE; Khabbaz RF; Lal RB; Kaplan JE
J Clin Microbiol; 1991 Jun; 29(6):1125-7. PubMed ID: 1864928
[TBL] [Abstract][Full Text] [Related]
12. The prevalence and significance of HTLV-I/II seroindeterminate Western blot patterns.
Abrams A; Akahata Y; Jacobson S
Viruses; 2011 Aug; 3(8):1320-31. PubMed ID: 21994781
[TBL] [Abstract][Full Text] [Related]
13. Serological speciation of human T-cell leukaemia virus infections using synthetic peptide antigens.
Tosswill JH; McAlpine L; Mortimer PP
J Med Virol; 1993 May; 40(1):83-5. PubMed ID: 8099946
[TBL] [Abstract][Full Text] [Related]
14. Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins.
Varma M; Rudolph DL; Knuchel M; Switzer WM; Hadlock KG; Velligan M; Chan L; Foung SK; Lal RB
J Clin Microbiol; 1995 Dec; 33(12):3239-44. PubMed ID: 8586709
[TBL] [Abstract][Full Text] [Related]
15. Sera of patients with rheumatoid arthritis contain antibodies to recombinant human T-lymphotrophic virus type I/II envelope glycoprotein p21.
Starkebaum G; Shasteen NM; Fleming-Jones RM; Loughran TP; Mannik M
Clin Immunol Immunopathol; 1996 May; 79(2):182-8. PubMed ID: 8620624
[TBL] [Abstract][Full Text] [Related]
16. Detection of human T-lymphotropic virus type-I/II env antibodies by immunoassays using recombinant fusion proteins.
Rudolph DL; Khabbaz RF; Folks TM; Lal RB
Diagn Microbiol Infect Dis; 1993 Jul; 17(1):35-9. PubMed ID: 8102953
[TBL] [Abstract][Full Text] [Related]
17. Detection of HTLV-I and HTLV-II infection in Africans using type-specific envelope peptides.
Goubau P; Desmyter J; Swanson P; Reynders M; Shih J; Surmont I; Kazadi K; Lee H
J Med Virol; 1993 Jan; 39(1):28-32. PubMed ID: 8093712
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Western immunoblot antigens and interpretive criteria for detection of antibody to human T-lymphotropic virus types I and II.
Gallo D; Diggs JL; Hanson CV
J Clin Microbiol; 1990 Sep; 28(9):2045-50. PubMed ID: 1977764
[TBL] [Abstract][Full Text] [Related]
19. Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.
Noraz N; Benichou S; Madaule P; Tiollais P; Vernant JC; Desgranges C
Virology; 1993 Mar; 193(1):80-8. PubMed ID: 7679862
[TBL] [Abstract][Full Text] [Related]
20. HTLV-I/II indeterminate serology and natural killer cell expansion.
Picchio GR; Bare P; Savignano R; Perez-Bianco R; Yamashita M; Hayami M
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(4):428-31. PubMed ID: 8673555
[No Abstract] [Full Text] [Related]
[Next] [New Search]
